Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects (Q34229605)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects |
scientific article |
Statements
1 reference
Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects (English)
1 reference
Joo-Youn Cho
1 reference
Jung Won Kim
1 reference
Jung-Ryul Kim
1 reference
Sojeong Yi
1 reference
Kwang-Hee Shin
1 reference
Hyun-Suk Shin
1 reference
Seo Hyun Yoon
1 reference
Dal-Hyun Kim
1 reference
Sang-Goo Shin
1 reference
In-Jin Jang
1 reference
Kyung-Sang Yu
1 reference
1 November 2011
1 reference
1 reference
33
1 reference
11
1 reference
1819-1830
1 reference
Identifiers
1 reference
1 reference